MYO
Myomo, Inc.$1.25-0.05 (-3.85%)Prev Close$1.30·MCap$54.1M·P/E—·Vol297.1K·Yield—
▲
Buys (12M)
7
$254.5K
▼
Sells (12M)
7
$288.7K
◆
Net Activity
Net Seller
$34.1K
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Myomo, Inc. (MYO) has been mixed between buying and selling, with 7 insider purchases totaling $254.5K and 7 insider sales totaling $288.7K. The most recent insider transaction was by Kovelman Harry (officer: Chief Medical Officer), who sold $19.7K worth of shares on Sep 14, 2026. Myomo, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $54.1M.
MYO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 15,488 | $1.27 | $19.7K | 90,245 |
| Sep 4, 2026 | Morris Milton Mayo | director | Sell | 15,000 | $1.41 | $21.1K | 208,391 |
| Aug 24, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 17,500 | $1.73 | $30.3K | 105,733 |
| Aug 21, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 17,250 | $1.73 | $29.9K | 105,983 |
| Jun 9, 2026 | KIRK THOMAS F | director | Buy | 40,002 | $1.27 | $50.8K | 693,865 |
| Jun 8, 2026 | Mitchell Micah | officer: Chief Commercial Officer | Sell | 90,231 | $0.86 | $77.7K | 109,478-45% |
| Jun 1, 2026 | KIRK THOMAS F | director | Buy | 25,000 | $0.99 | $24.8K | 653,863 |
| May 28, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 32,000 | $1.01 | $32.2K | 120,154 |
| May 18, 2026 | KIRK THOMAS F | director | Buy | 75,006 | $0.91 | $68.2K | 628,863 |
| May 15, 2026 | Mitchell Micah | officer: Chief Commercial Officer | Sell | 90,231 | $0.86 | $77.7K | 109,478-45% |
| Mar 16, 2026 | KIRK THOMAS F | director | Buy | 72,000 | $0.71 | $51.1K | 553,857 |
| Mar 12, 2026 | Getz Heather C | director | Buy | 70,000 | $0.73 | $51.0K | 111,754+168% |
| Nov 24, 2025 | KIRK THOMAS F | Buy | 7,437 | $0.72 | $5.4K | 481,857 | |
| Nov 21, 2025 | Crowley Thomas Aloysius Jr. | Buy | 4,385 | $0.74 | $3.2K | 75,748 | |
| Aug 26, 2025 | KIRK THOMAS F | Buy | 50,000 | $1.15 | $57.5K | 474,420 | |
| Aug 19, 2025 | KIRK THOMAS F | Buy | 50,000 | $1.10 | $55.0K | 424,420 | |
| Aug 18, 2025 | GUDONIS PAUL R | Chief Executive Officer | Buy | 50,000 | $0.95 | $47.3K | 1,259,013 |
| May 15, 2025 | GUDONIS PAUL R | Chief Executive Officer | Buy | 30,000 | $3.22 | $96.6K | 1,051,671 |
| May 15, 2025 | KIRK THOMAS F | Buy | 38,767 | $3.25 | $126.0K | 344,700 | |
| May 14, 2025 | KIRK THOMAS F | Buy | 50,000 | $3.35 | $167.5K | 305,933 | |
| Mar 14, 2025 | KIRK THOMAS F | Buy | 7,400 | $5.00 | $37.0K | 255,933 | |
| Mar 14, 2025 | Mitchell Micah | Chief Commercial Officer | Sell | 48,000 | $5.16 | $247.6K | 140,572-25% |
| Mar 13, 2025 | Kovelman Harry | Chief Medical Officer | Sell | 30,000 | $5.50 | $165.0K | 97,973 |
| Sep 9, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 6,700 | $3.76 | $25.2K | 123,556 |
| Sep 5, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 2,029 | $4.01 | $8.1K | 130,395 |
| May 31, 2024 | KIRK THOMAS F | Buy | 50,000 | $3.50 | $175.0K | 236,499+27% | |
| May 17, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 35,426 | $3.69 | $130.8K | 98,009-27% |
| Mar 18, 2024 | KIRK THOMAS F | Buy | 50,000 | $3.50 | $175.0K | 186,499+37% | |
| Dec 14, 2023 | KIRK THOMAS F | Buy | 50,000 | $3.10 | $155.0K | 136,499+58% | |
| Sep 11, 2023 | Morris Milton Mayo | Buy | 15,000 | $1.06 | $15.9K | 77,933 | |
| Aug 31, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 48,400 | $0.74 | $36.0K | 878,245 |
| Aug 30, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 79,500 | $0.76 | $60.6K | 829,845 |
| Aug 30, 2023 | HENRY DAVID A | Chief Financial Officer | Buy | 41,666 | $0.60 | $25.0K | 352,193 |
| Aug 30, 2023 | Kovelman Harry | Chief Medical Officer | Buy | 8,333 | $0.60 | $5.0K | 149,556 |
| Jun 30, 2023 | Crowley Thomas Aloysius Jr. | Director | Sell | 12,901 | $2.09 | $27.0K | 9,401-58% |
| Jan 18, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 307,692 | $0.33 | $100.0K0.8% OS | 483,345+175% |
| Jan 18, 2023 | HENRY DAVID A | Chief Financial Officer | Buy | 76,923 | $0.33 | $25.0K | 163,527+89% |
| Jan 18, 2023 | Mitchell Micah | Chief Commerical Officer | Buy | 15,384 | $0.33 | $5.0K | 64,815+31% |
| Nov 22, 2022 | HENRY DAVID A | Chief Financial Officer | Buy | 9,000 | $0.55 | $5.0K | 86,604 |
| Aug 8, 2022 | Crowley Thomas Aloysius Jr. | Director | Sell | 7,141 | $1.71 | $12.2K | 12,901-36% |
| Mar 16, 2022 | GUDONIS PAUL R | Chief Executive Officer | Buy | 5,000 | $4.22 | $21.1K | 92,018 |
| Mar 11, 2022 | GUDONIS PAUL R | Chief Executive Officer | Buy | 5,000 | $4.63 | $23.1K | 87,018 |
| Nov 16, 2021 | GUDONIS PAUL R | Chief Executive Officer | Buy | 1,000 | $9.86 | $9.9K | 82,018 |
| Nov 16, 2021 | HENRY DAVID A | Chief Financial Officer | Buy | 1,000 | $8.86 | $8.9K | 35,618 |
MYO Insider Buying Activity
The following table shows recent insider purchases of Myomo, Inc. (MYO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | KIRK THOMAS F | director | Buy | 40,002 | $1.27 | $50.8K | 693,865 |
| Jun 1, 2026 | KIRK THOMAS F | director | Buy | 25,000 | $0.99 | $24.8K | 653,863 |
| May 18, 2026 | KIRK THOMAS F | director | Buy | 75,006 | $0.91 | $68.2K | 628,863 |
| Mar 16, 2026 | KIRK THOMAS F | director | Buy | 72,000 | $0.71 | $51.1K | 553,857 |
| Mar 12, 2026 | Getz Heather C | director | Buy | 70,000 | $0.73 | $51.0K | 111,754+168% |
| Nov 24, 2025 | KIRK THOMAS F | Buy | 7,437 | $0.72 | $5.4K | 481,857 | |
| Nov 21, 2025 | Crowley Thomas Aloysius Jr. | Buy | 4,385 | $0.74 | $3.2K | 75,748 | |
| Aug 26, 2025 | KIRK THOMAS F | Buy | 50,000 | $1.15 | $57.5K | 474,420 | |
| Aug 19, 2025 | KIRK THOMAS F | Buy | 50,000 | $1.10 | $55.0K | 424,420 | |
| Aug 18, 2025 | GUDONIS PAUL R | Chief Executive Officer | Buy | 50,000 | $0.95 | $47.3K | 1,259,013 |
| May 15, 2025 | GUDONIS PAUL R | Chief Executive Officer | Buy | 30,000 | $3.22 | $96.6K | 1,051,671 |
| May 15, 2025 | KIRK THOMAS F | Buy | 38,767 | $3.25 | $126.0K | 344,700 | |
| May 14, 2025 | KIRK THOMAS F | Buy | 50,000 | $3.35 | $167.5K | 305,933 | |
| Mar 14, 2025 | KIRK THOMAS F | Buy | 7,400 | $5.00 | $37.0K | 255,933 | |
| May 31, 2024 | KIRK THOMAS F | Buy | 50,000 | $3.50 | $175.0K | 236,499+27% | |
| Mar 18, 2024 | KIRK THOMAS F | Buy | 50,000 | $3.50 | $175.0K | 186,499+37% | |
| Dec 14, 2023 | KIRK THOMAS F | Buy | 50,000 | $3.10 | $155.0K | 136,499+58% | |
| Sep 11, 2023 | Morris Milton Mayo | Buy | 15,000 | $1.06 | $15.9K | 77,933 | |
| Aug 31, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 48,400 | $0.74 | $36.0K | 878,245 |
| Aug 30, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 79,500 | $0.76 | $60.6K | 829,845 |
| Aug 30, 2023 | HENRY DAVID A | Chief Financial Officer | Buy | 41,666 | $0.60 | $25.0K | 352,193 |
| Aug 30, 2023 | Kovelman Harry | Chief Medical Officer | Buy | 8,333 | $0.60 | $5.0K | 149,556 |
| Jan 18, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 307,692 | $0.33 | $100.0K0.8% OS | 483,345+175% |
| Jan 18, 2023 | HENRY DAVID A | Chief Financial Officer | Buy | 76,923 | $0.33 | $25.0K | 163,527+89% |
| Jan 18, 2023 | Mitchell Micah | Chief Commerical Officer | Buy | 15,384 | $0.33 | $5.0K | 64,815+31% |
| Nov 22, 2022 | HENRY DAVID A | Chief Financial Officer | Buy | 9,000 | $0.55 | $5.0K | 86,604 |
| Mar 16, 2022 | GUDONIS PAUL R | Chief Executive Officer | Buy | 5,000 | $4.22 | $21.1K | 92,018 |
| Mar 11, 2022 | GUDONIS PAUL R | Chief Executive Officer | Buy | 5,000 | $4.63 | $23.1K | 87,018 |
| Nov 16, 2021 | GUDONIS PAUL R | Chief Executive Officer | Buy | 1,000 | $9.86 | $9.9K | 82,018 |
| Nov 16, 2021 | HENRY DAVID A | Chief Financial Officer | Buy | 1,000 | $8.86 | $8.9K | 35,618 |
MYO Insider Selling Activity
The following table shows recent insider sales of Myomo, Inc. (MYO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 15,488 | $1.27 | $19.7K | 90,245 |
| Sep 4, 2026 | Morris Milton Mayo | director | Sell | 15,000 | $1.41 | $21.1K | 208,391 |
| Aug 24, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 17,500 | $1.73 | $30.3K | 105,733 |
| Aug 21, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 17,250 | $1.73 | $29.9K | 105,983 |
| Jun 8, 2026 | Mitchell Micah | officer: Chief Commercial Officer | Sell | 90,231 | $0.86 | $77.7K | 109,478-45% |
| May 28, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 32,000 | $1.01 | $32.2K | 120,154 |
| May 15, 2026 | Mitchell Micah | officer: Chief Commercial Officer | Sell | 90,231 | $0.86 | $77.7K | 109,478-45% |
| Mar 14, 2025 | Mitchell Micah | Chief Commercial Officer | Sell | 48,000 | $5.16 | $247.6K | 140,572-25% |
| Mar 13, 2025 | Kovelman Harry | Chief Medical Officer | Sell | 30,000 | $5.50 | $165.0K | 97,973 |
| Sep 9, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 6,700 | $3.76 | $25.2K | 123,556 |
| Sep 5, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 2,029 | $4.01 | $8.1K | 130,395 |
| May 17, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 35,426 | $3.69 | $130.8K | 98,009-27% |
| Jun 30, 2023 | Crowley Thomas Aloysius Jr. | Director | Sell | 12,901 | $2.09 | $27.0K | 9,401-58% |
| Aug 8, 2022 | Crowley Thomas Aloysius Jr. | Director | Sell | 7,141 | $1.71 | $12.2K | 12,901-36% |
MYO Insiders
Similar Stocks to MYO
SYK
Stryker Corporation
$281.11-0.32%
$105.57B
BSX
Boston Scientific Corporation
$43.93-2.48%
$66.83B
EW
Edwards Lifesciences Corporation
$85.82+0.33%
$49.62B
DXCM
DexCom, Inc.
$86.69+2.37%
$31.33B
ZBH
Zimmer Biomet Holdings, Inc.
$99.10+2.61%
$18.09B
GMED
Globus Medical, Inc.
$74.78-1.29%
$10.01B
GKOS
Glaukos Corporation
$172.13+0.61%
$9.87B
PODD
Insulet Corp.
$139.63+1.32%
$9.14B